Autoimmune complications in chronic lymphocytic leukaemia (CLL).

Best Practice & Research. Clinical Haematology
Clive S Zent, Neil E Kay

Abstract

Patients with B-chronic lymphocytic leukaemia /small lymphocytic lymphoma (CLL) have a 5-10% risk of developing autoimmune complications, which primarily cause cytopaenia. These autoimmune cytopaenias can occur at any stage of CLL and do not have independent prognostic significance. The most common autoimmune complication is autoimmune haemolytic anaemia with a lower frequency of immune thrombocytopaenia and pure red blood cell aplasia and only rarely, autoimmune granulocytopaenia (AIG). Autoimmune cytopaenia should always be considered in the differential diagnosis of cytopaenia in patients with CLL. Patients with CLL can also have more than one form of autoimmune cytopaenia, which can occur together with bone-marrow failure. Treatment is usually effective but rarely curative for autoimmune cytopaenia complicating CLL. Optimal therapy will depend on a timely and accurate diagnosis of autoimmune cytopaenia and should be individualised according to the severity of the cytopaenia and the presence or absence of concomitant progressive CLL requiring therapy.

References

Oct 1, 1988·Journal of Autoimmunity·B M BrökerP Collins
Jul 1, 1986·Journal of Clinical Pathology·T J HamblinB J Young
Dec 1, 1980·The Journal of Experimental Medicine·F K StevensonA L Tutt
Aug 1, 1994·American Journal of Hematology·M A Ruess-BorstC A Müller
Apr 1, 1993·The Journal of Clinical Investigation·J P LeddyS I Rosenfeld
Jan 11, 2003·The Hematology Journal : the Official Journal of the European Haematology Association·Giuseppe MarottaFrancesco Lauria
Sep 2, 2003·American Journal of Hematology·Mouhammed J KyasaClive S Zent
Jan 24, 2004·Leukemia & Lymphoma·Francesco ZajaRenato Fanin
Dec 1, 2004·The Hematology Journal : the Official Journal of the European Haematology Association·Despina PantelidouGeorge Bourikas
Sep 10, 2005·Blood·Lindsay M MortonMartha S Linet
Oct 8, 2005·Current Opinion in Immunology·Jeffrey A Bluestone, Qizhi Tang
Apr 18, 2006·Seminars in Oncology·Terry J Hamblin
Jul 11, 2006·American Journal of Hematology·Giovanni D'ArenaAntonio Pinto
Feb 7, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ian W FlinnMartin S Tallman
Oct 2, 2007·Blood Reviews·Charles H Packman
Jun 25, 2008·British Journal of Haematology·Bethan Psaila, James B Bussel
Oct 22, 2008·Leukemia Research·Terry J Hamblin

❮ Previous
Next ❯

Citations

Jan 19, 2011·Haematologica·Kate HodgsonCarol Moreno
Jun 2, 2014·Haematologica·Paolo Ghia, Michael Hallek
May 22, 2013·Clinical & Developmental Immunology·Giovanni D'ArenaPellegrino Musto
May 24, 2012·Expert Opinion on Investigational Drugs·Lukáš Smolej
Dec 17, 2014·Journal of Clinical and Experimental Hematopathology : JCEH·Futoshi IiokaHitoshi Ohno
Sep 22, 2010·Autoimmunity Reviews·Caterina DefendentiPiercarlo Sarzi Puttini
Sep 19, 2015·Pediatric Hematology and Oncology·Dilek Gurlek GokcebayNamik Ozbek
May 4, 2011·British Journal of Haematology·Kate HodgsonEmili Montserrat
Jun 11, 2014·American Journal of Hematology·Carlo ViscoFrancesco Rodeghiero
Jul 22, 2015·British Journal of Haematology·Tom G RiderJoel A Newman
Nov 9, 2011·Clinical Lymphoma, Myeloma & Leukemia·Moonjung Jung, Lawrence Rice
Jul 25, 2013·Journal of Autoimmunity·Birgit Knoechel, Jens G Lohr
Jun 1, 2014·Revista brasileira de reumatologia·Juliana Miranda de LucenaBranca Dias Batista de Souza
May 18, 2016·World Journal of Surgical Oncology·Victoria BîrluţiuIoan Sorin Zaharie
Jul 3, 2016·Critical Reviews in Oncology/hematology·Lydia ScarfòPaolo Ghia
Sep 8, 2016·Oral and Maxillofacial Surgery Clinics of North America·Ehlie K Bruno, Jeffrey D Bennett
Nov 20, 2016·The FEBS Journal·Clive S Zent, Michael R Elliott
May 5, 2016·Journal of Investigative Medicine High Impact Case Reports·Janice P DutcherPeter H Wiernik
Oct 21, 2017·Journal of Investigative Medicine High Impact Case Reports·Parita SoniKupfer Yizhak
Jul 31, 2019·Clinical Chemistry·Erna Lenters-WestraRobbert J Slingerland
Sep 9, 2019·International Journal of Hematology·Nicholas WrightJoshua Field
Sep 1, 2015·Asian Pacific Journal of Cancer Prevention : APJCP·Syeda Alia AbbasSyed Mohammad Irfan
Jul 18, 2018·Journal of Clinical and Experimental Hematopathology : JCEH·Takaharu SuzukiSadao Aoki
Dec 29, 2017·American Journal of Hematology·Yuanquan YangFrancisco Hernandez-Ilizaliturri
Sep 5, 2017·Journal of Neuromuscular Diseases·Angela RussellLawrence Korngut
Feb 16, 2017·Current Hematologic Malignancy Reports·Mazie Tsang, Sameer A Parikh
May 10, 2017·Wiener klinische Wochenschrift·Cengiz Demir, Ömer Ekinci
Dec 7, 2018·JAMA : the Journal of the American Medical Association·Corbin EuleSrikanth Nagalla
Feb 11, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Carlo ViscoAgostino Cortelezzi
May 20, 2016·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Eric A EngelsRuth M Pfeiffer
Apr 4, 2021·Journal of Clinical Medicine·Stinne TranekærHenrik Frederiksen
Aug 17, 2021·The Cancer Journal·Nil Albiol, Carol Moreno

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenocortical Carcinoma

Adrenocortical carcinoma (ACC) is a rare malignancy of the adrenal cortex, associated with a generally dismal prognosis owing to its aggressive behavior. Here are the latest discoveries pertaining to this disease.

Autoimmune Lymphoproliferative Syndrome

Autoimmune lymphoproliferative syndrome (ALPS) is a rare genetic disorder of abnormal lymphocyte survival caused by defective Fas mediated apoptosis. Discover the latest research on ALPS here.

Autoimmune Hemolytic Anemia

Autoimmune hemolytic anemia (AIHA) occurs when antibodies directed against the person's own red blood cells (RBCs) cause them to burst (lyse), leading to an insufficient number of oxygen-carrying red blood cells in the circulation. Discover the latest research on AIHA here.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.